MIF4GD Antikörper (Isoform 1, N-Term)

Produktnummer ABIN4916659

Produktdetails anti-MIF4GD Antikörper

Target: MIF4GD (MIF4G Domain Containing (MIF4GD))

Bindungsspezifität: Isoform 1, N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MIF4GD Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Spezifität: Reacts with human MIF4GD protein, isoform 1

Aufreinigung: Purified (protein A)

Immunogen: Synthetic peptide derived from N terminal part of human MIF4GD protein, isoform 1.

Anwendungsinformationen

Applikationshinweise:

Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only :
- WB : 1/100 to 1/2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Must be reconstituted in distilled water.

Buffer: Tris 0,1M, glycine 0,1M, sucrose 2 %

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.

Haltbarkeit: 24 months

Details zu MIF4GD

Target: MIF4GD (MIF4G Domain Containing (MIF4GD))

Andere Bezeichnung: MIF4G Domain-Containing Protein (MIF4GD Produkte)

Synonyme: AD023 antikoerper, MIFD antikoerper, SLIP1 antikoerper, 1110014L05Rik antikoerper, 2310075G12Rik antikoerper, RGD1309685 antikoerper, MIF4GD antikoerper, zgc:64152 antikoerper, zgc:110826 antikoerper, ad023 antikoerper, mif4gd antikoerper, mif4gd-a antikoerper, mif4gd-b antikoerper, mifd antikoerper, slip1 antikoerper, MIF4G domain containing antikoerper, MIF4G domain containing a antikoerper, MIF4G domain containing b antikoerper, MIF4G domain containing L homeolog antikoerper, MIF4G domain containing S homeolog antikoerper, MIF4GD antikoerper, Mif4gd antikoerper, mif4gda antikoerper, mif4gdb antikoerper, mif4gd.L antikoerper, mif4gd.S antikoerper

Hintergrund: Belongs to the MIF4GD family. Functions in replication-dependent translation of histone mRNAs which differ from other eukaryotic mRNAs in that they do not end with a poly-A tail but a stem-loop. May participate in circularizing those mRNAs specifically enhancing their translation. Interacts with EIF4G1, EIF4G2 and SLBP.